TY - JOUR
T1 - FAS-L, IL-10, and double-negative CD4-CD8- TCR α/β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
AU - Magerus-Chatinet, Aude
AU - Stolzenberg, Marie Claude
AU - Loffredo, Maria S.
AU - Neven, Bénédicte
AU - Schaffner, Catherine
AU - Ducrot, Nicolas
AU - Arkwright, Peter D.
AU - Bader-Meunier, Brigitte
AU - Barbot, José
AU - Blanche, Stéphane
AU - Casanova, Jean Laurent
AU - Debré, Marianne
AU - Ferster, Alina
AU - Fieschi, Claire
AU - Florkin, Benoit
AU - Galambrun, Claire
AU - Hermine, Olivier
AU - Lambotte, Olivier
AU - Solary, Eric
AU - Thomas, Caroline
AU - Deist, Francoise Le
AU - Picard, Capucine
AU - Fischer, Alain
AU - Rieux-Laucat, Frédéric
PY - 2009/3/26
Y1 - 2009/3/26
N2 - Autoimmune lymphoproliferative syndrome (ALPS) is characterized by splenomegaly, lymphdenopathy, hypergammaglobu-linemia, accumulation of double-negative TCRαβ+ CD4-CD8- T cells (DNT cells), and autoimmunity. Previously, DNT cell detection and a functional defect of T cells in a FAS-induced apoptosis test in vitro had been used for ALPS diagnosis. However, a functional defect can also be detected in mutation-positive relatives (MPRs) who remain free of any ALPS-related disease. In contrast, lymphocytes from patients carrying a somatic mutation of FAS exhibit normal sensitivity to FAS-induced apoptosis in vitro. We assessed the soluble FAS-L concentration in the plasma of ALPS patients carrying FAS mutations. Overall, we showed that determination of the FAS-L represents, together with the IL-10 concentration and the DNT cell percentage, a reliable tool for the diagnosis of ALPS.
AB - Autoimmune lymphoproliferative syndrome (ALPS) is characterized by splenomegaly, lymphdenopathy, hypergammaglobu-linemia, accumulation of double-negative TCRαβ+ CD4-CD8- T cells (DNT cells), and autoimmunity. Previously, DNT cell detection and a functional defect of T cells in a FAS-induced apoptosis test in vitro had been used for ALPS diagnosis. However, a functional defect can also be detected in mutation-positive relatives (MPRs) who remain free of any ALPS-related disease. In contrast, lymphocytes from patients carrying a somatic mutation of FAS exhibit normal sensitivity to FAS-induced apoptosis in vitro. We assessed the soluble FAS-L concentration in the plasma of ALPS patients carrying FAS mutations. Overall, we showed that determination of the FAS-L represents, together with the IL-10 concentration and the DNT cell percentage, a reliable tool for the diagnosis of ALPS.
UR - http://www.scopus.com/inward/record.url?scp=64049096371&partnerID=8YFLogxK
U2 - 10.1182/blood-2008-09-179630
DO - 10.1182/blood-2008-09-179630
M3 - Article
C2 - 19176318
AN - SCOPUS:64049096371
SN - 0006-4971
VL - 113
SP - 3027
EP - 3030
JO - Blood
JF - Blood
IS - 13
ER -